|

FK-PC101 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Cellvax Therapeutics Inc1

Indications

  • Prostate Cancer Patients Undergoing Radical Prostatectomy1
  • Prostate Cancers1
  • Prostate CA1
  • High Risk Prostate Cancer1
  • Prostate Cancer (Post Prostatectomy)1

Chicago, Illinois1 trial

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.